CARTER'S INC (CRI) Fundamental Analysis & Valuation

NYSE:CRI • US1462291097

Current stock price

37.2 USD
-0.88 (-2.31%)
At close:
37.2 USD
0 (0%)
After Hours:

This CRI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. CRI Profitability Analysis

1.1 Basic Checks

  • In the past year CRI was profitable.
  • CRI had a positive operating cash flow in the past year.
  • In the past 5 years CRI has always been profitable.
  • Each year in the past 5 years CRI had a positive operating cash flow.
CRI Yearly Net Income VS EBIT VS OCF VS FCFCRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

1.2 Ratios

  • CRI's Return On Assets of 3.50% is in line compared to the rest of the industry. CRI outperforms 57.78% of its industry peers.
  • Looking at the Return On Equity, with a value of 9.71%, CRI is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • CRI has a Return On Invested Capital of 5.63%. This is comparable to the rest of the industry: CRI outperforms 53.33% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CRI is in line with the industry average of 9.53%.
  • The last Return On Invested Capital (5.63%) for CRI is well below the 3 year average (10.50%), which needs to be investigated, but indicates that CRI had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.5%
ROE 9.71%
ROIC 5.63%
ROA(3y)6.85%
ROA(5y)8.24%
ROE(3y)19.32%
ROE(5y)24.84%
ROIC(3y)10.5%
ROIC(5y)12.8%
CRI Yearly ROA, ROE, ROICCRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • CRI has a Profit Margin (3.10%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of CRI has declined.
  • CRI has a Operating Margin of 4.97%. This is comparable to the rest of the industry: CRI outperforms 48.89% of its industry peers.
  • In the last couple of years the Operating Margin of CRI has declined.
  • CRI has a Gross Margin of 45.36%. This is in the lower half of the industry: CRI underperforms 60.00% of its industry peers.
  • In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
Industry RankSector Rank
OM 4.97%
PM (TTM) 3.1%
GM 45.36%
OM growth 3Y-25.65%
OM growth 5Y-12.92%
PM growth 3Y-26.15%
PM growth 5Y-2.98%
GM growth 3Y-0.35%
GM growth 5Y0.65%
CRI Yearly Profit, Operating, Gross MarginsCRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

4

2. CRI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
  • The number of shares outstanding for CRI has been increased compared to 1 year ago.
  • The number of shares outstanding for CRI has been reduced compared to 5 years ago.
  • The debt/assets ratio for CRI is higher compared to a year ago.
CRI Yearly Shares OutstandingCRI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CRI Yearly Total Debt VS Total AssetsCRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.69 indicates that CRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CRI (2.69) is comparable to the rest of the industry.
  • The Debt to FCF ratio of CRI is 8.26, which is on the high side as it means it would take CRI, 8.26 years of fcf income to pay off all of its debts.
  • CRI has a Debt to FCF ratio of 8.26. This is comparable to the rest of the industry: CRI outperforms 51.11% of its industry peers.
  • A Debt/Equity ratio of 0.61 indicates that CRI is somewhat dependend on debt financing.
  • CRI has a Debt to Equity ratio of 0.61. This is in the lower half of the industry: CRI underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 8.26
Altman-Z 2.69
ROIC/WACC0.51
WACC11%
CRI Yearly LT Debt VS Equity VS FCFCRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 2.51 indicates that CRI has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.51, CRI is doing good in the industry, outperforming 68.89% of the companies in the same industry.
  • A Quick Ratio of 1.44 indicates that CRI should not have too much problems paying its short term obligations.
  • CRI's Quick ratio of 1.44 is fine compared to the rest of the industry. CRI outperforms 62.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 1.44
CRI Yearly Current Assets VS Current LiabilitesCRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

3

3. CRI Growth Analysis

3.1 Past

  • The earnings per share for CRI have decreased strongly by -42.83% in the last year.
  • Measured over the past years, CRI shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.52% on average per year.
  • CRI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.32%.
  • CRI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.85% yearly.
EPS 1Y (TTM)-42.83%
EPS 3Y-20.55%
EPS 5Y-3.52%
EPS Q2Q%-26.64%
Revenue 1Y (TTM)-17.32%
Revenue growth 3Y-3.37%
Revenue growth 5Y-0.85%
Sales Q2Q%7.65%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.68% on average over the next years.
  • The Revenue is expected to grow by 1.82% on average over the next years.
EPS Next Y-11.06%
EPS Next 2Y1.66%
EPS Next 3Y3.68%
EPS Next 5YN/A
Revenue Next Year3.66%
Revenue Next 2Y2.38%
Revenue Next 3Y1.82%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRI Yearly Revenue VS EstimatesCRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CRI Yearly EPS VS EstimatesCRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

5

4. CRI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.72, the valuation of CRI can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of CRI indicates a rather cheap valuation: CRI is cheaper than 86.67% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of CRI to the average of the S&P500 Index (27.42), we can say CRI is valued rather cheaply.
  • The Price/Forward Earnings ratio is 12.05, which indicates a correct valuation of CRI.
  • Based on the Price/Forward Earnings ratio, CRI is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, CRI is valued a bit cheaper.
Industry RankSector Rank
PE 10.72
Fwd PE 12.05
CRI Price Earnings VS Forward Price EarningsCRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 80.00% of the companies in the same industry are more expensive than CRI, based on the Enterprise Value to EBITDA ratio.
  • 64.44% of the companies in the same industry are more expensive than CRI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.99
EV/EBITDA 7.45
CRI Per share dataCRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.66%
EPS Next 3Y3.68%

5

5. CRI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.63%, CRI has a reasonable but not impressive dividend return.
  • CRI's Dividend Yield is rather good when compared to the industry average which is at 1.39. CRI pays more dividend than 84.44% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, CRI pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.63%

5.2 History

  • On average, the dividend of CRI grows each year by 16.75%, which is quite nice.
  • CRI has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)16.75%
Div Incr Years0
Div Non Decr Years0
CRI Yearly Dividends per shareCRI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • CRI pays out 62.77% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of CRI is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP62.77%
EPS Next 2Y1.66%
EPS Next 3Y3.68%
CRI Yearly Income VS Free CF VS DividendCRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
CRI Dividend Payout.CRI Dividend Payout, showing the Payout Ratio.CRI Dividend Payout.PayoutRetained Earnings

CRI Fundamentals: All Metrics, Ratios and Statistics

CARTER'S INC

NYSE:CRI (4/24/2026, 8:04:00 PM)

After market: 37.2 0 (0%)

37.2

-0.88 (-2.31%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)04-24
Earnings (Next)07-23
Inst Owners109.9%
Inst Owner Change-0.1%
Ins Owners3.9%
Ins Owner Change12.94%
Market Cap1.37B
Revenue(TTM)2.90B
Net Income(TTM)89.79M
Analysts52.86
Price Target37.74 (1.45%)
Short Float %9.31%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield 2.63%
Yearly Dividend3.2
Dividend Growth(5Y)16.75%
DP62.77%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.81%
Min EPS beat(2)-0.32%
Max EPS beat(2)7.93%
EPS beat(4)2
Avg EPS beat(4)-6.49%
Min EPS beat(4)-56.97%
Max EPS beat(4)23.39%
EPS beat(8)6
Avg EPS beat(8)14.24%
EPS beat(12)10
Avg EPS beat(12)18.23%
EPS beat(16)12
Avg EPS beat(16)15.42%
Revenue beat(2)0
Avg Revenue beat(2)-1.6%
Min Revenue beat(2)-2.52%
Max Revenue beat(2)-0.67%
Revenue beat(4)1
Avg Revenue beat(4)-0.17%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)2.56%
Revenue beat(8)3
Avg Revenue beat(8)0.12%
Revenue beat(12)4
Avg Revenue beat(12)0.26%
Revenue beat(16)6
Avg Revenue beat(16)-0.08%
PT rev (1m)6.32%
PT rev (3m)22.52%
EPS NQ rev (1m)6.43%
EPS NQ rev (3m)-55.66%
EPS NY rev (1m)-0.58%
EPS NY rev (3m)30.88%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)1.97%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)4.3%
Valuation
Industry RankSector Rank
PE 10.72
Fwd PE 12.05
P/S 0.47
P/FCF 19.99
P/OCF 11.21
P/B 1.48
P/tB 3.21
EV/EBITDA 7.45
EPS(TTM)3.47
EY9.33%
EPS(NY)3.09
Fwd EY8.3%
FCF(TTM)1.86
FCFY5%
OCF(TTM)3.32
OCFY8.92%
SpS78.59
BVpS25.08
TBVpS11.59
PEG (NY)N/A
PEG (5Y)N/A
Graham Number44.253 (18.96%)
Profitability
Industry RankSector Rank
ROA 3.5%
ROE 9.71%
ROCE 6.99%
ROIC 5.63%
ROICexc 7.37%
ROICexgc 10.78%
OM 4.97%
PM (TTM) 3.1%
GM 45.36%
FCFM 2.37%
ROA(3y)6.85%
ROA(5y)8.24%
ROE(3y)19.32%
ROE(5y)24.84%
ROIC(3y)10.5%
ROIC(5y)12.8%
ROICexc(3y)13.27%
ROICexc(5y)17.02%
ROICexgc(3y)20.07%
ROICexgc(5y)25.99%
ROCE(3y)13.04%
ROCE(5y)15.9%
ROICexgc growth 3Y-25.78%
ROICexgc growth 5Y-15.59%
ROICexc growth 3Y-25.93%
ROICexc growth 5Y-14.26%
OM growth 3Y-25.65%
OM growth 5Y-12.92%
PM growth 3Y-26.15%
PM growth 5Y-2.98%
GM growth 3Y-0.35%
GM growth 5Y0.65%
F-Score4
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 8.26
Debt/EBITDA 2.85
Cap/Depr 97.18%
Cap/Sales 1.85%
Interest Coverage 4.08
Cash Conversion 61.41%
Profit Quality 76.44%
Current Ratio 2.51
Quick Ratio 1.44
Altman-Z 2.69
F-Score4
WACC11%
ROIC/WACC0.51
Cap/Depr(3y)95.82%
Cap/Depr(5y)77.84%
Cap/Sales(3y)1.95%
Cap/Sales(5y)1.64%
Profit Quality(3y)138.58%
Profit Quality(5y)100.81%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.83%
EPS 3Y-20.55%
EPS 5Y-3.52%
EPS Q2Q%-26.64%
EPS Next Y-11.06%
EPS Next 2Y1.66%
EPS Next 3Y3.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.32%
Revenue growth 3Y-3.37%
Revenue growth 5Y-0.85%
Sales Q2Q%7.65%
Revenue Next Year3.66%
Revenue Next 2Y2.38%
Revenue Next 3Y1.82%
Revenue Next 5YN/A
EBIT growth 1Y-57.64%
EBIT growth 3Y-28.15%
EBIT growth 5Y-13.66%
EBIT Next Year35.87%
EBIT Next 3Y24.79%
EBIT Next 5YN/A
FCF growth 1Y-71.71%
FCF growth 3Y12.66%
FCF growth 5Y-34.18%
OCF growth 1Y-59.06%
OCF growth 3Y11.44%
OCF growth 5Y-26.96%

CARTER'S INC / CRI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CARTER'S INC (CRI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CRI.


What is the valuation status for CRI stock?

ChartMill assigns a valuation rating of 5 / 10 to CARTER'S INC (CRI). This can be considered as Fairly Valued.


How profitable is CARTER'S INC (CRI) stock?

CARTER'S INC (CRI) has a profitability rating of 5 / 10.


What is the valuation of CARTER'S INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CARTER'S INC (CRI) is 10.72 and the Price/Book (PB) ratio is 1.48.


What is the earnings growth outlook for CARTER'S INC?

The Earnings per Share (EPS) of CARTER'S INC (CRI) is expected to decline by -11.06% in the next year.